These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 32035061)
1. CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers. Kumaravel S; Singh S; Roy S; Venkatasamy L; White TK; Sinha S; Glaser SS; Safe SH; Chakraborty S Am J Pathol; 2020 Apr; 190(4):900-915. PubMed ID: 32035061 [TBL] [Abstract][Full Text] [Related]
2. Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts. Lau TS; Chung TK; Cheung TH; Chan LK; Cheung LW; Yim SF; Siu NS; Lo KW; Yu MM; Kulbe H; Balkwill FR; Kwong J J Pathol; 2014 Jan; 232(1):43-56. PubMed ID: 24014111 [TBL] [Abstract][Full Text] [Related]
3. Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4 Hart M; Nickl L; Walch-Rueckheim B; Krammes L; Rheinheimer S; Diener C; Taenzer T; Kehl T; Sester M; Lenhof HP; Keller A; Meese E J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229509 [TBL] [Abstract][Full Text] [Related]
4. CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7. Puchert M; Obst J; Koch C; Zieger K; Engele J Cytokine; 2020 Jan; 125():154809. PubMed ID: 31437604 [TBL] [Abstract][Full Text] [Related]
5. Epithelial mesenchymal transition induced by the CXCL9/CXCR3 axis through AKT activation promotes invasion and metastasis in tongue squamous cell carcinoma. Li Z; Liu J; Li L; Shao S; Wu J; Bian L; He Y Oncol Rep; 2018 Mar; 39(3):1356-1368. PubMed ID: 29286143 [TBL] [Abstract][Full Text] [Related]
6. The CXCR3-CXCL11 signaling axis mediates macrophage recruitment and dissemination of mycobacterial infection. Torraca V; Cui C; Boland R; Bebelman JP; van der Sar AM; Smit MJ; Siderius M; Spaink HP; Meijer AH Dis Model Mech; 2015 Mar; 8(3):253-69. PubMed ID: 25573892 [TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological characteristics of the CD8 Chai X; Sun Z; Li H; Zhu L; Liu X; Liu Y; Pei F; Chang Q Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Jun; 56(3):512-518. PubMed ID: 38864138 [TBL] [Abstract][Full Text] [Related]
8. Association of chemokines IP-10/CXCL10 and I-TAC/CXCL11 with insulin resistance and enhance leukocyte endothelial arrest in obesity. Moreno B; Hueso L; Ortega R; Benito E; Martínez-Hervas S; Peiro M; Civera M; Sanz MJ; Piqueras L; Real JT Microvasc Res; 2022 Jan; 139():104254. PubMed ID: 34534571 [TBL] [Abstract][Full Text] [Related]
9. CXCL11 promotes self-renewal and tumorigenicity of α2δ1 Zhang Y; Zhao W; Li S; Lv M; Yang X; Li M; Zhang Z Cancer Lett; 2019 May; 449():163-171. PubMed ID: 30771435 [TBL] [Abstract][Full Text] [Related]
10. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond. Karin N Front Immunol; 2020; 11():976. PubMed ID: 32547545 [TBL] [Abstract][Full Text] [Related]
11. Effects of Tobacco Smoking on the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma. de la Iglesia JV; Slebos RJC; Martin-Gomez L; Wang X; Teer JK; Tan AC; Gerke TA; Aden-Buie G; van Veen T; Masannat J; Chaudhary R; Song F; Fournier M; Siegel EM; Schabath MB; Wadsworth JT; Caudell J; Harrison L; Wenig BM; Conejo-Garcia J; Hernandez-Prera JC; Chung CH Clin Cancer Res; 2020 Mar; 26(6):1474-1485. PubMed ID: 31848186 [TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding. Cox JH; Dean RA; Roberts CR; Overall CM J Biol Chem; 2008 Jul; 283(28):19389-99. PubMed ID: 18411283 [TBL] [Abstract][Full Text] [Related]
13. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma. Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis. Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110 [TBL] [Abstract][Full Text] [Related]
15. Crosstalk between head and neck cancer cells and lymphatic endothelial cells promotes tumor metastasis via CXCL5-CXCR2 signaling. Lee BS; Jang JY; Seo C; Kim CH FASEB J; 2021 Jan; 35(1):e21181. PubMed ID: 33231340 [TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin inhibits colorectal cancer progression by inhibiting CXCL11 secreted by cancer-associated fibroblasts and the CXCR3/PI3K/AKT pathway. Lu C; Zhang C Clin Transl Oncol; 2023 Jan; 25(1):160-172. PubMed ID: 36129606 [TBL] [Abstract][Full Text] [Related]
17. Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis. Li Q; Sun J; Cao Y; Liu B; Li L; Mohammadtursun N; Zhang H; Dong J; Wu J Biomed Pharmacother; 2020 Mar; 123():109735. PubMed ID: 31864210 [TBL] [Abstract][Full Text] [Related]
18. The CXCL11-CXCR3A axis influences the infiltration of CD274 and IDO1 in oral squamous cell carcinoma. Wang X; Zhang J; Zhou G J Oral Pathol Med; 2021 Apr; 50(4):362-370. PubMed ID: 33187013 [TBL] [Abstract][Full Text] [Related]
19. Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach. Costantini S; Raucci R; De Vero T; Castello G; Colonna G Cytokine; 2013 Oct; 64(1):316-21. PubMed ID: 23773308 [TBL] [Abstract][Full Text] [Related]
20. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus. Jiang Y; Cao W; Wu K; Qin X; Wang X; Li Y; Yu B; Zhang Z; Wang X; Yan M; Xu Q; Zhang J; Chen W J Exp Clin Cancer Res; 2019 Aug; 38(1):365. PubMed ID: 31429766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]